Advances in single-cell surface engineering: nano-coating and core–shell strategies for probiotics delivery in inflammatory bowel disease
Archives of Microbiology · 2026
DOI: 10.1007/s00203-026-04907-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Keke Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Zhenjiang Hospital of Chinese Traditional and Western Medicine, Zhenjiang, 212002, China. Hauptthemen laut MEDLINE: Probiotics, Inflammatory Bowel Diseases, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Scientific research project of Huai'an Municipal Health Commissio, Medical Innovation Application Research of Huai'an Science and Technology Bureau, Scientific research project of Huai’an Municipal Health Commissio.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disorder with a complex pathogenesis involving oxidative stress, intestinal barrier damage, gut microbiota dysbiosis, and immune imbalance. Conventional therapies merely alleviate symptoms but fail to achieve a radical cure, and long-term use is associated with adverse reaction and drug resistance. Probiotics represent a potential therapeutic strategy for IBD by regulating gut microecology, repairing the intestinal barrier, and modulating mucosal immunity, yet their clinical efficacy is severely limited by poor gastrointestinal tolerance, low viability, and inadequate colonization after oral administration. Inspired by bacterial self-protection mechanism, this review highlights innovative biomedical material-based probiotics delivery strategies for IBD, including microencapsulation, single-cell encapsulation, disease-targeted modification, and nanozyme integration. These engineered delivery systems innovatively endow probiotics with acid/bile salt resistance, site-specific targeting to inflamed intestinal mucosa, and reactive oxygen species scavenging capacity, while synergistically optimizing the pathological microenvironment of IBD to enhance probiotics colonization and functional activity. We further emphasize the clinical translation potential of these intelligent delivery platform, and discuss the key design principles for improving their biocompatibility, targeting efficiency, and scalability. This review aims to provide theoretical reference and experimental support for the development of intelligent, efficient probiotics delivery system with clinical translation potential, which may help address the unmet therapeutic needs of IBD and act as a novel adjunctive therapy for clinical practice in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Zhenjiang Hospital of Chinese Traditional and Western Medicine, Zhenjiang, 212002, China.
- The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, No. 62, Huaihai Road (S.), Huai'an, 223002, China. y13852034764@163.com.
Förderung
- Scientific research project of Huai'an Municipal Health Commissio
- Medical Innovation Application Research of Huai'an Science and Technology Bureau
- Scientific research project of Huai’an Municipal Health Commissio
- Medical Innovation Application Research of Huai’an Science and Technology Bureau
Zitieren
APA
Wang, K., & Yan, C. (2026). Advances in single-cell surface engineering: nano-coating and core–shell strategies for probiotics delivery in inflammatory bowel disease. Archives of Microbiology. https://doi.org/10.1007/s00203-026-04907-5
Vancouver
Wang K, Yan C. Advances in single-cell surface engineering: nano-coating and core–shell strategies for probiotics delivery in inflammatory bowel disease. Archives of Microbiology. 2026. doi:10.1007/s00203-026-04907-5
BibTeX
@article{Wang2026,
author = {Wang, Keke and Yan, Chao},
title = {Advances in single-cell surface engineering: nano-coating and core–shell strategies for probiotics delivery in inflammatory bowel disease},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-026-04907-5}
}
EUVIMED